(197 days)
Apogee 2300 (K173000)
Not Found
No
The document does not mention AI, ML, deep learning, or any related terms. The description focuses on standard ultrasound imaging modes and features.
No.
The device is described as an "ultrasound evaluation" and "Digital Color Ultrasound Imaging System" used for diagnostic purposes (imaging various anatomical sites), not for treating or preventing disease.
Yes
The "Intended Use / Indications for Use" section states that the system is for "ultrasound evaluation" of various anatomical sites, which implies the use of the device to obtain information for medical diagnosis. The "Summary of Performance Studies" also mentions "Marketing Clearance of Diagnostic Ultrasound Systems and Transducers", further confirming its diagnostic nature.
No
The device description explicitly states it is a "Digital Color Ultrasound Imaging System" and mentions supporting various transducers (linear, convex, phased array, endocavity), which are hardware components. While it includes software, it is not solely software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the system is for "ultrasound evaluation" of various anatomical sites and applications. This involves using ultrasound technology to visualize internal structures and assess their characteristics.
- Device Description: The description details the different operating modes and capabilities of an ultrasound imaging system. These are all related to generating and processing ultrasound images.
- Lack of Mention of In Vitro Testing: There is no mention of the device being used to test samples (like blood, urine, tissue) outside of the body. IVD devices are specifically designed for such in vitro testing.
- Focus on Imaging: The entire description and intended use revolve around the process of medical imaging using ultrasound.
IVD devices are used to examine specimens obtained from the human body to provide information for diagnosis, monitoring, or screening. This ultrasound system is used to directly image the human body.
N/A
Intended Use / Indications for Use
The system is intended to be used by a trained/qualified physician in a hospital or clinical setting for ultrasound evaluation of fetal, abdominal, pediatric, small organ (thyroid, testes, breast), neonatal cephalic, musculoskeletal (conventional and superficial), cardiac (adult and pediatric), peripheral vascular, trans-rectal, obstetrics/ gynecology and urology applications in B-Mode (B, 2B, 4B), M-Mode, CFM, CPA, DPA, PWD, CWD, Combined (B, M, CFM, CPA, DPA, PWD, XBeam, Panoscope), and others (3D, Trapezoidal /Extended Sector Imaging, Elastography, Anatomical M-mode, TDI, THI, MFI, ECG, VS Flow, Color M, DICOM).
Product codes (comma separated list FDA assigned to the subject device)
IYN, IYO, ITX
Device Description
The SIUI Apogee 1000 series (Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee 1000B/W/ Apogee 1 series (Apogee 1T/ Apogee 1T/ Apogee 1G) Digital Color Ultrasound Imaging System is capable of the following operating modes: B-Mode (B, 2B, 4B), M-Mode, CFM, CPA, DPA, PWD, CWD, Combined(B, M, CFM, CPA, DPA, PWD, CWD, XBeam, Panoscope), and others (3D, Trapezoidal /Extended Sector Imaging, Elastography, Anatomical M-mode, THI, TDI, DPA, MFI, ECG, VS Flow, Color M, DICOM).
The system is designed for use in linear, convex, phased array scanning modes and supports linear, convex, phased array and endocavity (trans-vaginal and trans-rectal) transducers. The system has cine review, image zoom, measurements and calculations, image storage and review, printing and recording capabilities.
This system is a Track 3 device and the software used in Apogee 1000 series / Apogee 1 series Digital Color Ultrasound Imaging System is Ultrasound Software by SIUI and is based on the predicate device. The Level of Concern for the Ultrasound Software is Moderate.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
fetal, abdominal, pediatric, small organ (thyroid, testes, breast), neonatal cephalic, musculoskeletal (conventional and superficial), cardiac (adult and pediatric), peripheral vascular, trans-rectal, obstetrics/ gynecology and urology
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained/qualified physician in a hospital or clinical setting
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical testing demonstrated compliance with FDA guidance and International Standards, indicating the device is as safe, effective, and performs as well as the predicate device. Clinical testing was not deemed necessary to demonstrate substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Apogee 2300 (K173000)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square and the words "U.S. Food & Drug Administration".
Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI) % Flower Cai Liaison Manager 77 Jinsha Road Shantou. Guangdong 515041 CHINA
August 19, 2021
Re: K210317
Trade/Device Name: Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee 1000B/W / Apogee 1U/ Apogee 1T/ Apogee 1G Digital Color Doppler Ultrasound Imaging System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: Class II Product Code: IYN, IYO, ITX Dated: July 8, 2021 Received: July 19, 2021
Dear Flower Cai:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
For
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K210317
Device Name
Apogee 1000/ Apogee 1000Ned Apogee 1000Exp/ Apogee 1000Exp/ Apogee 1000B/W / Apogee 10/ Apogee 1G Digital Color Doppler Ultrasound Imaging System
Indications for Use (Describe)
The system is intended to be used by a trained/qualified physician in a hospital or clinical setting for ultrasound evaluation of fetal, abdominal, pediatric, small organ (thyroid, testes, breast), neonatal cephalic, musculoskeletal (conventional and superficial), cardiac (adult and pediatric), peripheral vascular, trans-rectal, obstetrics/ gynecology and urology applications in B-Mode (B, 2B, 4B), M-Mode, CFM, CPA, DPA, PWD, CWD, Combined (B, M, CFM, CPA, DPA, PWD, XBeam, Panoscope), and others (3D, Trapezoidal /Extended Sector Imaging, Elastography, Anatomical M-mode, TDI, THI, MFI, ECG, VS Flow, Color M, DICOM).
Type of Use (Select one or both, as applicable) | |
---|---|
☒ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
This summary of 510(k) safety and effectiveness information is provided in accordance with the requirements of SMDA 1990 and 21 CFR 807.92(c).
The assigned 510(k) number is: K210317
5.1 Submitter
Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)
77 Jinsha Road, Shantou, Guangdong 515041, China
Tel: 86-754-88250150
Fax: 86-754-88251499
Contact Person: Flower Cai
Shantou Institute of Ultrasonic Instruments Co., Ltd.
77 Jinsha Road, Shantou, Guangdong 515041, China
Date Prepared: July 8, 2021
5.2 Device
Name of Device:
Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee 1000B/W/ Apogee 1U/ Apogee 1T/ Apogee 1G Digital Color Doppler Ultrasound Imaging System
510(k) submitter: SIUI
Classification Name:
Ultrasonic pulsed Doppler imaging system | 90-IYN | (per 21 CFR 892.1550) |
---|---|---|
Ultrasonic pulsed echo imaging system | 90-IYO | (per 21 CFR 892.1560) |
Diagnostic ultrasonic transducer | 90-ITX | (per 21 CFR 892.1570) |
Regulatory Class: II
Product Code: IYN, IYO, ITX
4
5.3 Predicate Device
Name of Predicate Device: Apogee 2300 (K173000) | ||
---|---|---|
510(k) holder: SIUI | ||
Classification Name: | ||
Ultrasonic pulsed Doppler imaging system | 90-IYN | (per 21 CFR 892.1550) |
Ultrasonic pulsed echo imaging system | 90-IYO | (per 21 CFR 892.1560) |
Diagnostic ultrasonic transducer | 90-ITX | (per 21 CFR 892.1570) |
Regulatory Class: II | ||
Product Code: IYN, IYO, ITX |
5.4 Device Description
5.4.1 Description
The SIUI Apogee 1000 series (Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee 1000B/W/ Apogee 1 series (Apogee 1T/ Apogee 1T/ Apogee 1G) Digital Color Ultrasound Imaging System is capable of the following operating modes: B-Mode (B, 2B, 4B), M-Mode, CFM, CPA, DPA, PWD, CWD, Combined(B, M, CFM, CPA, DPA, PWD, CWD, XBeam, Panoscope), and others (3D, Trapezoidal /Extended Sector Imaging, Elastography, Anatomical M-mode, THI, TDI, DPA, MFI, ECG, VS Flow, Color M, DICOM).
The system is designed for use in linear, convex, phased array scanning modes and supports linear, convex, phased array and endocavity (trans-vaginal and trans-rectal) transducers. The system has cine review, image zoom, measurements and calculations, image storage and review, printing and recording capabilities.
This system is a Track 3 device and the software used in Apogee 1000 series / Apogee 1 series Digital Color Ultrasound Imaging System is Ultrasound Software by SIUI and is based on the predicate device. The Level of Concern for the Ultrasound Software is Moderate.
5.4.2 Comparisons of Apogee 1000 series and Apogee 1 series devices
Except for the cosmetic color, the Apogee 1000 series and Apogee 1 series are completely the same. Subject to market positioning, the Apogee 1000 series/ Apogee 1 series have different functional configurations. See the table below.
5
SIUI Apogee 1000 series/ Apogee 1 series Digital Color Doppler Ultrasound Imaging System
Product Model | Apogee 1000 series | Apogee 1 series | |||||||
---|---|---|---|---|---|---|---|---|---|
Apogee | |||||||||
1000 | Apogee | ||||||||
1000Neo | Apogee | ||||||||
1000Lite | Apogee | ||||||||
1000Exp | Apogee | ||||||||
1000B/W | Apogee | ||||||||
1U | Apogee | ||||||||
1T | Apogee | ||||||||
1G | |||||||||
Photo | Image: Apogee 1000Lite | Image: Apogee 1U | |||||||
Functional | |||||||||
configuration | Continuous | ||||||||
Wave | |||||||||
Doppler (CW) | ○ | ○ | ○ | √ | ○ | √ | ○ | ||
Trapezoidal/ | |||||||||
Extended | |||||||||
Sector Imaging | ○ | ○ | √ | ○ | √ | ○ | √ | ||
Panoscope | ○ | √ | ○ | ○ | √ | √ | √ |
Note: "○" means "option configuration", "√" means "standard configuration".
5.5 Indications for Use
The system is intended to be used by a trained/qualified physician in a hospital or clinical setting for ultrasound evaluation of fetal, abdominal, pediatric, small organ (thyroid, testes, breast), neonatal cephalic, musculoskeletal (conventional and superficial), cardiac (adult and pediatric), peripheral vascular, trans-vaginal, trans-rectal, obstetrics/ gynecology and urology applications in B-Mode (B, 2B, 4B), M-Mode, CFM, CPA, DPA, PWD, CWD, Combined (B, M, CFM, CPA, DPA, PWD, CWD, XBeam, Panoscope), and others (3D, Trapezoidal /Extended Sector Imaging, Elastography, Anatomical M-mode, TDI, THI, MFI, ECG, VS Flow, Color M, DICOM).
5.6 Comparison of Technological Characteristics with the Predicate Device
The Apogee 1000 series/Apogee 1 series Digital Color Doppler Ultrasound Imaging Systems is a multi-purpose diagnostic ultrasound system with accessories and proprietary software, and are substantially equivalent to predicate devices.
The comparison between the overall specifications of predicate device (Apogee 2300 (K173000)) and the subject device (Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee 1000B/W/ Apogee 1U/ Apogee 1T/ Apogee 1G) are as follows:
- Compared with the predicate device Apogee 2300, the subject devices have the same intended 1) use.
6
- In cosmetic design, the subject device has a smaller and lighter structure and appearance. 2) Subject to cosmetic changes, the PCBAs in the system are adjusted in their size and layout, while the overall circuit principle is not changed. The subject device and the predicate device use the same PC module, digital signal processing module, and ultrasound front-end module. Compared with the predicate device, the overall user interface of the subject device has not changed substantially, and the position of the probe connector is adjusted to the side of the device according to the cosmetic structure. As the overall structure dimensions become smaller, the number of probe connectors is less than that of the predicate device by 1. Furthermore, the structure of the monitor is optimized, not only maintaining the up and down invert function of the predicate device, but also to achieve a 90-degree rotation left and right, which improves the user experience.
- In terms of functions, compared with the predicate device, the subject device lacks the 4D 3) imaging mode, but both devices are the same in other ultrasonic diagnostic functions, imaging modes, file storage management, compatible peripherals, measurement and calculation functions.
- In probe configuration, the subject device supports three new probe models: P5FN, ECBP-1 and 4) ECBP-2. The application range of the P5FN probe (of the subject device) is the same as that of the P3FN probe for the predicate device, and the application range of the ECBP-2 probes (of the subject device) is the same as that of the ECBN probe for the predicate device.
-
- The subject device is similar in technological characteristics to the predicate device.
Any differences between the predicate and the new device have no impact on safety or efficacy of the new device and do not raise any new potential or increased safety risks, and the new device is equivalent in performance to existing legally marketed devices.
5.7 Non-clinical Testing Summary
The Apogee 1000 series/ Apogee 1 series Digital Color Doppler Ultrasound Imaging System comply with and/or were tested in accordance with the following FDA guidance and International Standards:
- . IEC 60601-1:2005+A1:2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance
- IEC60601-1-2:2014 Medical electrical equipment Part 1-2: General requirements for basic ● safety and essential performance - Collateral standard: Electromagnetic compatibility -Requirements and tests.
- IEC 60601-2-37:2007+AMD1:2015 Medical electrical equipment — Part 2-37:Particular requirements for the safety of ultrasonic medical diagnostic and monitoring equipment
7
- IEC 60601-2-25:2011 Medical electrical equipment - Part 2-25: Particular requirements for the basic safety and essential performance of electrocardiographs
- ISO 14971:2019 Medical device - Application of risk management to medical devices
- ISO 10993-1:2018 Biological evaluation of medical devices-Part1: Evaluation and testing within a risk management process
- ISO 10993-5:2009 Biological evaluation of medical devices-Part5: Tests for in vitro cytotoxicity ●
- ISO 10993-10:2010 Biological evaluation of medical devices - Part 10:Tests for irritation and skin sensitization
- IEC 62304:2006+AMD1:2015 Medical device software – Software life cycle processes
- IEC 60601-1-6:2010+A1:2013 Medical electrical equipment Part 1-6: General requirements for ● basic safety and essential performance – collateral standard: Usability
- IEC 62366-1:2015/COR1:2016 Medical devices Application of usability engineering to ● medical devices
- ISO 15223-1:2016 Medical devices Symbols to be used with medical device labels, labelling ● and information to be supplied - Part 1: General requirements
- ISO 13485 :2016 Medical devices - Quality management systems - Requirements for regulatory purposes
- Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices
- Marketing Clearance of Diagnostic Ultrasound Systems and Transducers
The subject device and the predicate device are comparable in terms of technical features, general functions, applications and intended uses. The test results showed compliance with the above standards. The non-clinical tests demonstrate that the subject device is as safe, as effective, and performs as well as the predicate.
5.8 Clinical Testing
Clinical testing is not necessary for the Apogee 1000 series/ Apogee 1 series Digital Color Doppler Ultrasound Imaging System in order to demonstrate substantial equivalence to the predicate device.
5.9 Conclusion
The subject device SIUI Apogee 1000 series (Apogee 1000) Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee 1000B/W)/ Apogee 1 series (Apogee 1U/ Apogee 1T/ Apogee 1G) Digital Color Doppler Ultrasound Imaging System and the predicate device SIUI Apogee 2300 Digital Color Doppler Ultrasound Imaging System are comparable in terms of technical features, general functions, applications and indications for use.
8
The nonclinical tests (discussed above) demonstrate that Apogee 1000 series (Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee 1000B/W// Apogee 1 series (Apogee 1U/ Apogee 1T/ Apogee 1G) Digital Color Doppler Ultrasound Imaging System performs as well as, and is substantially equivalent with respect to safety and effectiveness of the predicate device currently cleared for market.
9
Appendix
- Acronyms and full names of imaging modes
Acronym | Full Name |
---|---|
CFM | Color Flow Map |
CPA | Color Power Angio |
DPA | Directional Power Angio |
PWD | Pulsed Wave Doppler |
CWD | Continuous Wave Doppler |
THI | Tissue Harmonic Imaging |
TDI | Tissue Doppler Imaging |
MFI | Macro fidelity Imaging |
VS Flow | Vector Space Flow |
2. Equivalent Names of Subject Device
| Equivalent
Names of
Subject
Device | Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee
1000B/W/ Apogee 1U/ Apogee 1T/ Apogee 1G Digital Color Doppler
Ultrasound Imaging System |
|---------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Apogee 1000 Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1000Neo Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1000Lite Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1000Exp Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1000B/W Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1U Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1T Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1G Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/ Apogee 1000Exp/ Apogee
1000B/W/ Apogee 1U/ Apogee 1T/ Apogee 1G |
| | Apogee 1000 series (Apogee 1000/ Apogee 1000Neo/ Apogee 1000Lite/
Apogee 1000Exp/ Apogee 1000B/W)/ Apogee 1 series (Apogee 1U/ Apogee
1T/ Apogee 1G) Digital Color Doppler Ultrasound Imaging System |
| | Apogee 1000 series/ Apogee 1 series |